We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




How Cell Metabolism Adjusts to Iron Deficiency

By Biotechdaily staff writers
Posted on 26 Jan 2005
Researchers have found that when faced with iron deficiency, cells can reprogram their metabolism to reduce the production of iron-requiring proteins.

Investigators at Duke University (Durham, NC, USA) used the yeast Saccharomyces cerevisiae as a model representing human cells. More...
The yeast was grown in media containing a limited concentration of iron, and the effect of restricted iron availability on the cell's genetic machinery was determined.

The investigators found that under low iron conditions the yeast over-produced Cth2, an RNA binding protein. The increased activity of Cth2 interfered with the production of proteins that require iron to function. In a paper published in the January 14, 2005, issue of Cell, the investigators reported that Cth2 inhibited more than 80 genes.

"We discovered that iron deprivation actually reprograms the metabolism of the entire cell,” said senior author Dr. Dennis J. Thiele, professor of pharmacology and cancer biology at Duke University. "Literally hundreds of proteins require iron to carry out their proper function, so without this nutrient, there is a complete reorganization of how cellular processes occur. Current diagnostic markers for iron deficiency are not very sensitive, unless the deficiency is severe. Pinpointing the genes affected by iron deprivation should provide us with a genetic fingerprint of what patients with varying levels of iron deprivation look like.”

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Aspiration System
VACUSAFE
New
Multi-Chamber Washer-Disinfector
WD 390
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.